Skip to main content
Daniel Landers, MD, Obstetrics & Gynecology, Minneapolis, MN, M Health Fairview University of Minnesota Medical Center

DanielVLandersMD

Obstetrics & Gynecology Minneapolis, MN

Maternal & Fetal Medicine/High Risk

Professor, Vice Chair and MFM Division Director, Department of Ob-Gyn, University of Minnesota

Dr. Landers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Landers' full profile

Already have an account?

  • Office

    Dept Ob-Gyn, University of Minnesota (MMC-395)
    430 Delaware St., SE
    Minneapolis, MN 55455
    Phone+1 612-301-3414
    Fax+1 612-627-4191
  • Is this information wrong?

Summary

  • Board certified in Ob-Gyn and Maternal-Fetal Medicine and fellowship trained in Reproductive Infectious Diseases and Immunology at UCSF and Post Doc in Molecular Immunology, Stanford University
    Currently serving as:
    1) Executive Vice Chair, Dept. of Obstetrics, Gynecology and Women's Health, University of Minnesota Medical School.
    2) Physician Co-Chief, Women's and Children's Service Line, M Health Fairview Health System, Minneapolis, MN

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Allergy and Immunology, 1986 - 1988
  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Maternal-Fetal Medicine, 1984 - 1986
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Obstetrics and Gynecology, 1980 - 1984
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1980
  • California State University, Northridge
    California State University, NorthridgeB.S., Biology, 1972 - 1976

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - 2026
  • MN State Medical License
    MN State Medical License 2003 - 2025
  • ND State Medical License
    ND State Medical License 2013 - 2019
  • PA State Medical License
    PA State Medical License 1995 - 2002
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Maternal-Fetal Medicine

Awards, Honors, & Recognition

  • Top Doctors U.W. News & World Report, 2014-2023
  • Best Doctor for Women Minnesota Monthly Magazine, 2010, 2014-2023
  • Top Doctors Minneapolis-St. Paul Magazine, 2004-2023
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • A perinatal care quality and safety initiative: Are there financial rewards for improved quality?  
    Kozhimannil KB, Sommerness S, Rauk P, Gams R, Davis S, Miller K, Hirt C, Landers D, Joint Commission Journal on Quality and Patient Safety, 8/1/2013
  • High rate of severe fetal outcomes associated with maternal parvovirus B19 infection in pregnancy.  
    Beigi RH, Simhan HN, Weisenfeld HC, Landers DV, Inf Dis Ob Gynecol, 1/1/2008
  • Host immune consequences of asymptomatic Trichomonas Vaginalis infection in pregnancy.  
    Simhan HN, Anderson BL, Krohn MA, Heine PR, Martinez de Tejada B, Landers DV, Hillier SL, Am J Obstet Gynecol, 1/1/2007
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Characterization of neonatal outcomes of infants with congenital diaphragmatic hernia.
    Yamamura Y, Saltzman D, Acton R, Guiang S, Rauk P, Williams P, Landers D, Ramin K, J Ultrasound Med, 3/25/2006
  • Vaginal breech deliveries selected using computed tomographic pelvimetry are associated with fewer adverse outcomes.
    Jeyabalan A, Larkin R, Landers DV, Society for Maternal Fetal Medicine. Annual Meeting, 2/2/2004
  • Cytokine profiles in response to bacterial vaginosis in pregnancy before and after treatment with oral or vaginal metronidazole.
    Yudin MH, Landers DV, Hillier SL, IDSOG, Annual Meeting, 8/8/2002
  • Join now to see all

Press Mentions

  • New Peril Is Seen in a Blood Pressure Drug
    New Peril Is Seen in a Blood Pressure DrugJune 8th, 2006

Grant Support

  • Clinical Studies On Nnrti'S As MicrobicidesNational Institute Of Allergy And Infectious Diseases2002
  • Cellular Immune Responses In PregnancyEunice Kennedy Shriver National Institute Of Child Health &Human Development1986–1990

Professional Memberships

Hospital Affiliations